However, ERT often leads to the development of circulating immunoglobulin G (IgG) against rhGLA among male patients with Fabry disease, who completely lack the GLA protein, and these antibodies may cause allergic reactions and/or reduce the efficacy of ERT. Here, GLA is linked to Fabry disease.